newsfilter
← Latest News
GlobeNewswire·

Day One Announces Pricing of Public Offering of Common Stock

BRISBANE, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people